Clinical Trials Logo

Artificial Intelligence clinical trials

View clinical trials related to Artificial Intelligence.

Filter by:

NCT ID: NCT05981950 Recruiting - Clinical trials for Artificial Intelligence

Real-world of AI in Diagnosing Retinal Diseases

Start date: August 1, 2023
Phase:
Study type: Observational

The objective of this study is to apply an artificial intelligence algorithm to diagnose multi-retinal diseases in real-world settings. The effectiveness and accuracy of this algorithm are evaluated by sensitivity, specificity, positive predictive value, negative predictive value, and area under curve.

NCT ID: NCT05952193 Recruiting - Clinical trials for Artificial Intelligence

Evaluation of the POSOS Device for Iatrogenesis Detection in Clinical History? A Vignettes Study

YGenHiVi
Start date: June 21, 2023
Phase:
Study type: Observational

This study is a multicenter evaluation of diagnostic performance using simulated clinical vignettes. It aims to test the effectiveness of the POSOS app in detecting drug-induced iatrogenesis in urgent medical situations, an issue of public health importance. Participating physicians, who are randomly assigned to either use or not use POSOS, are categorized based on their years of experience. Vignettes, including a mixture of complex, simple, and non-iatrogenesis cases, are assigned to these doctors. During the simulation, physicians respond to their respective vignettes on the YgheniVi platform, with responses recorded at two intervals (5 min and 15 min). The supervising physicians subsequently fill out an e-CRF, providing further data on the time spent, the number of medical research applications used, and the overall user experience of POSOS. A doctor/pharmacist pair then corrects the answers to the vignettes.

NCT ID: NCT05916014 Recruiting - Clinical trials for Artificial Intelligence

AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis

Start date: June 1, 2023
Phase:
Study type: Observational

Grading endoscopic atrophy according to the Kimura-Takemoto classification can assess the risk of gastric neoplasia development. However, the false negative rate of chronic atrophic gastritis is high due to the varying diagnostic standardization and diagnostic experience and levels of endoscopists. Therefore, this study aims to develop an AI model to identify the Kimura-Takemoto classification.

NCT ID: NCT05862259 Recruiting - Immunotherapy Clinical Trials

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

Start date: August 10, 2023
Phase:
Study type: Observational

In this study, we collected the data of immunohistochemistry, gene detection, image, OS, PFS, Orr, and so on. Secondly, the database of immunotherapy for malignant tumor was established, and the predictive model was constructed to verify and establish the rationality and validity of the biomarkers and predictive system of immunotherapy

NCT ID: NCT05851716 Recruiting - Clinical trials for Artificial Intelligence

Upper Gastrointestinal Endoscopy Reporting System in Improving Report Quality

Start date: August 21, 2023
Phase:
Study type: Observational

The goal of this observational study is to evaluate the effectiveness of an AI-based reporting system for upper gastrointestinal endoscopy. The main question it aims to answer is: Whether the AI-based reporting system can improve the completeness of the reports, which are drafted by endoscopists with the AI assistance. Participants will undergo upper gastrointestinal endoscopy examination as routine. The junior endoscopists will draft the report with the assiatance of the AI system. And the senior and expert endoscopists will draft the report using the traditional reporting system without AI assistance.

NCT ID: NCT05810428 Recruiting - Virtual Reality Clinical Trials

Artificial Intelligence to Predict Surgical Outcomes and Assess Pain Neuromodulation in Trigeminal Neuralgia Subjects

Start date: April 6, 2023
Phase: N/A
Study type: Interventional

Trigeminal neuralgia (TN) is the most common cause of facial pain. Medical treatment is the first therapeutic choice whereas surgery, including Gamma Knife radiosurgery (GKRS), is indicated in case of pharmacological therapy failure. However, about 20% of subjects lack adequate pain relief after surgery. Virtual reality (VR) technology has been explored as a novel tool for reducing pain perception and might be the breakthrough in treatment-resistant cases. The investigators will conduct a prospective randomized comparative study to detect the effectiveness of GKRS aided by VR-training vs GKRS alone in TN patients. In addition, using MRI and artificial intelligence (AI), the investigators will identify pre-treatment abnormalities of central nervous system circuits associated with pain to predict response to treatment. The investigators expect that brain-based biomarkers, with clinical features, will provide key information in the personalization of treatment options and bring a huge impact in the management and understanding of pain in TN.

NCT ID: NCT05754268 Recruiting - Clinical trials for Postoperative Complications

Establishment, Verification and Clinical Application of Chinese Version of Surgical Risk Assessment System

CSRAS
Start date: January 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to establish and verify the Chinese version of surgical risk assessment system and explore its clinical application. The main questions it aims to answer are: The process of establishing a Chinese version of surgical risk assessment system; What is the accuracy of the system; How can the system be used in clinic; How does this system compare with other systems (such as NSQIP). Participants will comprehensively collect the general information, examination and pathological information of the patients, using machine learning and artificial intelligence methods for data processing. Finally, the Chinese version of the surgical risk assessment system will be established. After the system is established, investigators will evaluate the accuracy of the system and compare it with other related systems.

NCT ID: NCT05739331 Recruiting - Lung Cancer Clinical Trials

Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence

Start date: May 1, 2023
Phase:
Study type: Observational

To evaluate the usefulness of Deep neural network (DNN) in the evaluation of mediastinal and hilar lymph nodes with Endobronchial ultrasound (EBUS). The study will explore the feasibility of DNN to identify lymph nodes and blood vessel examined with EBUS.

NCT ID: NCT05534178 Recruiting - Quality of Life Clinical Trials

Machine Learning Model to Predict HOLS and Mortality After Discharge in Hospitalized Oncologic Patients

PLANTOLOGY
Start date: February 15, 2020
Phase:
Study type: Observational [Patient Registry]

The study aims to understand which are the most relevant parameters at admission which may allow to predict the hospital length of stay (HOLS) and mortality after discharge of oncologic hospitalized patients. This is the first multicentric prospective observational study that tries to understand the complexity of the hospitalized oncologic patients. A comprehensive analysis will be performed with the help of the nutrition, nursery, internal medicine and oncology teams.

NCT ID: NCT05482269 Recruiting - Clinical trials for Artificial Intelligence

Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

PEAICTPA
Start date: January 1, 2011
Phase:
Study type: Observational

The investigators aim to build a predictive tool for Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography.